INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Grant or awardVerified data

Ryan Renee reported NPCE

Director · NeuroPace Inc · NeuroPace Inc — Stock Option (Right to Buy)

Side
A
Value
—
Shares
5,368
Price
—
Executed
Jun 5, 2026
Disclosed
Jun 5, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jun 5 executedJun 5, 2026 disclosed

NPCE · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NPCE

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$4,680
    335 sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$5,059
    358 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$5,434
    335 sh
    		Jun 24, 2026Jun 25, 2026
    traded Jun 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    KR
    Kumar RakhiDirector
    NPCENeuroPace Inc
    Grant or award
    		A$15K
    989 sh
    		Jun 19, 2026Jun 22, 2026
    traded Jun 19, 2026
    		+3dSEC FORM 4

    Evidence

    13
    KR
    Kumar RakhiDirector
    NPCENeuroPace Inc
    Grant or award
    		A—
    2,890 sh
    		Jun 5, 2026Jun 5, 2026
    traded Jun 5, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KR
    Kumar RakhiDirector
    NPCENeuroPace Inc
    Grant or award
    		A—
    5,368 sh
    		Jun 5, 2026Jun 5, 2026
    traded Jun 5, 2026
    		+0dSEC FORM 4

    Evidence

    9
    RR
    Ryan ReneeDirector
    NPCENeuroPace Inc
    Grant or award
    		A—
    2,890 sh
    		Jun 5, 2026Jun 5, 2026
    traded Jun 5, 2026
    		+0dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$6,107
    358 sh
    		May 27, 2026May 28, 2026
    traded May 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$18K
    1,341 sh
    		Mar 24, 2026Mar 25, 2026
    traded Mar 24, 2026
    		+1dSEC FORM 4

    Evidence

    13
    KR
    Kumar RakhiDirector
    NPCENeuroPace Inc
    Grant or award
    		A$15K
    1,153 sh
    		Mar 20, 2026Mar 23, 2026
    traded Mar 20, 2026
    		+3dSEC FORM 4

    Evidence

    13
    KR
    Kumar RakhiDirector
    NPCENeuroPace Inc
    Grant or award
    		A$15K
    904 sh
    		Dec 19, 2025Dec 23, 2025
    traded Dec 19, 2025
    		+4dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$22K
    1,338 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$5,891
    357 sh
    		Nov 27, 2025Dec 1, 2025
    traded Nov 27, 2025
    		+4dSEC FORM 4

    Evidence

    9
    MM
    Morrell MarthaCHIEF MEDICAL OFFICER
    NPCENeuroPace Inc
    Tax withholding
    		F$41K
    3,051 sh
    		Nov 20, 2025Nov 24, 2025
    traded Nov 20, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001855576-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 5, 2026
    Published
    Jun 5, 2026
    Ingested by INSIDER
    Nov 5, 03:54 UTC
    Last re-read
    Nov 5, 03:54 UTC

    Extracted facts

    Filer
    Ryan Renee
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    NeuroPace Inc — Stock Option (Right to Buy)
    Ticker
    NPCE
    Shares
    5,368
    Price per share
    $0
    Execution date (reported)
    Jun 5, 2026
    Owned after transaction
    5,368 shares
    Days from execution to publication
    0

    What this establishes

    Ryan Renee filed this Form 4 reporting a grant or award of NPCE on Jun 5, 2026. It became public on Jun 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Ryan Reneecik:0001855576
    Issuer
    NeuroPace Inccik:0001528287

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.